Anti-CD47/PD-L1 antibody (Chinese Academy Of Sciences)

N/A

Report date: 2025/02/18 15:10:33

Base Information

Drug NameAnti-CD47/PD-L1 antibody (Chinese Academy Of Sciences)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCluster of differentiation 47 inhibitorsProgrammed death-ligand 1 blockers

TargetsCluster of differentiation 47Programmed death-ligand 1

Therapy Area/IndicationsRejection of liver transplantation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences

China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences

Inactive CompaniesN/A

Active IndicationsRejection of liver transplantation

Inactive IndicationsN/A

Other Information

ATC CodeN/A